When I was in my 20s, I was diagnosed with cancer over a phone call. What a way to practice medicine, but I felt something I didn’t expect: relief. Not because the diagnosis was easy — it wasn’t — but because the not‑knowing had been worse. The fear lived in…
For people with chronic obstructive pulmonary disease (COPD), characterized by cough and shortness of breath, Anoro Elipta (umeclidinium-vilanterol) may work better than other approved COPD medications at reducing the risk of disease flares. That’s according to a new federally funded study that used U.S. insurance data to compare…
A novel test based on the levels and composition of certain proteins in mucus, called mucins, may help assess lung health in people with chronic obstructive pulmonary disease (COPD), according to a new study. Findings show that higher Mucin Quantitative Score (MUCQ) values were significantly associated with worse lung…
The first person with chronic obstructive pulmonary disease (COPD) has now been dosed with BBT002, an experimental medication being developed by Bambusa Therapeutics, in an ongoing Phase 1b clinical trial. The trial (NCT06944925) is evaluating BBT002’s safety and pharmacological properties against a placebo in up to 98…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
